Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Sunrun Chief Accounting Officer Maria Barak sold 8,039 shares on April 9, 2026, through a Rule 10b5-1 trading plan, realizing $109,879 at a weighted average price of $13.6683. The transaction comes as Sunrun's stock has swung markedly - down 29% over six months but up 121% over the past year - and follows a quarter of strong revenue growth that has…
Eric Sprott and an affiliated Ontario entity purchased 200,000 Class A shares of Hycroft Mining Holding Corp on April 9, 2026, paying between $38.28 and $39.06 per share for a total of $7.73 million. The buying comes as the stock trades at $37.50 after a substantial one-year rally, and follows an updated mineral resource estimate showing materially…
Jeff E. Knight, Chief Development & Operating Officer of Crinetics Pharmaceuticals (CRNX), sold 85,163 shares on April 8, 2026 under a pre-arranged Rule 10b5-1 plan for $3.415 million and exercised options to acquire 78,434 shares for $1.758 million the same day. The company reported better-than-expected Q4 2025 results and has filed a Marketing Au…
Crestview Partners, a roughly 10% owner of Select Water Solutions Inc. (WTTR), sold a total of 3,096,223 Class A shares at $15.12 on April 8, 2026, for $36.7 million. The deal also included a redemption of LLC units that converted into 2,430,240 Class A shares and the cancellation of an equal number of Class B shares for no consideration. These mov…
Quality Industrial Corp (QIND) executive Safir Sanjeeb reported the sale of 1,000,000 common shares on November 26, 2024, as part of a stock purchase agreement with Fusion Fuel Green PLC. In the exchange he received 46,314 Series A Convertible Preferred Shares of Fusion Fuel; the QIND shares were recorded with an as-converted per-share value of $2.…
Airbnb Chief Financial Officer Elinor Mertz sold 3,750 Class A shares on April 8, 2026, at $130.99 per share for roughly $491,212 under a Rule 10b5-1 plan. The transaction was reported on a Form 4 signed April 10, 2026, and follows a $2.5 billion senior-notes offering used to repay $2.0 billion of convertible notes. Analysts have maintained mostly …
Reshma P. Shetty, a director and President & Founder of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), sold 26,271 shares of Class A common stock between April 8 and April 9, 2026, raising roughly $175,067. The transactions followed option exercises tied to the vesting of performance-based restricted stock units, and the sales were executed to mee…
Scott Thomas, Cirrus Logic’s Executive Vice President and General Counsel, disposed of 9,942 shares of the company’s common stock on April 9, 2026, for roughly $1.59 million at a weighted average price of $160.11. The same day he exercised options to acquire an identical number of shares at $68.56 per share under a Rule 10b5-1 plan adopted November…
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) founder and CEO Jason R. Kelly sold 206,782 Class A shares on April 8 and April 9, 2026, for roughly $1.37 million at prices between $6.397 and $6.93 per share. The transactions followed the exercise of performance-based restricted stock units that resulted in the acquisition of 425,898 shares on April 7 a…
Barry Canton, who holds roughly 10% of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), sold 26,271 Class A shares for about $175,067 across transactions on April 8 and April 9, 2026. The Form 4 filing shows the sales occurred at prices between $6.397 and $6.93 per share. The filing also reports Canton exercised performance-based restricted stock units …
Dianthus Therapeutics' Executive Vice President, CFO and CBO executed a sale of 8,224 shares on April 9, 2026, realizing $738,844 at an average price of $89.84, while simultaneously exercising options to acquire the same number of shares at $17.88. The trades were carried out under a Rule 10b5-1 plan adopted in December 2025. The company recently c…
Noah Goodman, Kymera Therapeutics' Chief Business Officer, sold shares worth roughly $500,582 on April 9, 2026, after exercising options the same day. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan and were disclosed on a Form 4 filing with the Securities and Exchange Commission. The company has also recorded recent pa…
Horizon Kinetics Asset Management LLC, a ten percent owner of Texas Pacific Land Corp (NYSE: TPL), reported buying one share of TPL on April 9, 2026 at $401.64 per share, a transaction listed as totaling $401. The firm now directly holds 3,435,493 shares. The disclosure arrives as the stock has experienced short-term weakness and notable analyst at…
Virtuix Holdings Inc. Chief Executive Jan Roger Goetgeluk sold $91,079 of company stock across two trades on April 8 and April 9, 2026, under a Rule 10b5-1 plan. The transactions coincided with the company reporting a series of strategic partnerships and corporate actions, including a Cooperative Research and Development Agreement with the Naval Po…
Village Super Market Inc.'s chief executive, John James Sumas, sold 12,702 Class A shares on April 8, 2026, generating about $548,218. The transaction occurred as the stock trades close to its 52-week high and after strong six-month gains. The company also declared quarterly cash dividends and remains engaged in litigation with Wakefern Food Corp.
Clark Joseph Gates, senior vice president at Penguin Solutions (NASDAQ: PENG), sold 12,546 shares on April 9, 2026, receiving $282,882 in proceeds. The transaction, executed under a pre-established Rule 10b5-1 trading plan, left Gates with 99,726 shares. The move coincides with Penguin Solutions reporting second-quarter fiscal 2026 revenue of $343 …
Exzeo Group Chief Executive Paresh Patel acquired 2,000 shares on April 9, 2026, spending $31,480 at $15.74 per share, according to a Form 4 filing. The purchase comes as Exzeo shares trade at $14.91, down materially year-to-date, and follows fourth-quarter and full-year 2025 results that met analyst expectations.
Omada Health President Shao Wei-Li sold 2,829 shares on April 8, 2026 under a trading plan established last August, generating $35,945. The company recently posted its first GAAP profit for fiscal 2025 with notable revenue and member growth, even as the stock has fallen about 50% over six months and analysts trimmed price targets amid valuation pre…
Millstreet Capital Management LLC sold 399,929 shares of Diebold Nixdorf Inc on April 8, 2026 for $82.4158 per share, realizing proceeds of $32.96 million. The sale took place while Diebold Nixdorf stock trades near a 52-week high and after the company reported stronger-than-expected fourth-quarter 2025 results and an upcoming S&P SmallCap 600 addi…
MarketAxess Holdings Inc. General Counsel Scott Pintoff sold 100 shares of the company's common stock on April 10, 2026, according to an SEC Form 4 filing. The transaction generated $17,196 and leaves Pintoff with 11,986 shares. Separately, MarketAxess reported fourth-quarter 2025 results with earnings per share above expectations and revenue sligh…
Resideo Technologies director Nina Richardson sold 2,789 shares on August 12, 2025, for total proceeds of $82,749 under a Rule 10b5-1 plan adopted in November 2024. The transaction leaves Richardson with 57,886 shares. The insider sale coincides with a 143% rise in REZI shares over the past year and comes amid mixed company financials: Q4 adjusted …
Didier Papadopoulos, President of Aircraft OEM at Joby Aviation (NYSE: JOBY), sold 271 shares on April 9, 2026, for $2,295 under a 10b5-1 trading plan. The transaction, reported on a Form 4, leaves him with 144,788 shares. The sale coincides with Joby’s recent operational milestones including FAA-conforming flight testing of aircraft N547JX, demons…
Forager Fund L.P. and affiliated parties purchased a combined $2.41 million of Repay Holdings Corp (RPAY) stock on April 1 and April 2, 2026, acquiring nearly 950,000 shares at prices between $2.42 and $2.60 per share. The transactions raise the group’s total holdings to 10,192,937 shares as the company moves forward with a roughly $372 million cas…
Immunovant Chief Technology Officer Jay S. Stout sold 10,132 shares on April 8, 2026, netting about $251,577 to satisfy tax-withholding obligations tied to vested RSUs. The transactions occurred as the stock traded near $24.50 and amid recent Phase 3 results for batoclimab that failed to meet the pre-specified primary endpoint. Analysts have respon…
Forager Fund L.P. and related parties acquired $2,304,426 of Repay Holdings Corp (NASDAQ: RPAY) Class A shares across three trades from April 7 to April 9, 2026, according to a Form 4/A filing. The purchases came as RPAY shares have slid roughly 38% over six months and amid Repay’s announced $372 million acquisition of Kubra Data Transfer Ltd., a d…
